Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Bacterium or component thereof or substance produced by said...
Patent
1979-05-14
1980-06-17
Friedman, Stanley J.
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Bacterium or component thereof or substance produced by said...
A61K 31475
Patent
active
042084148
ABSTRACT:
Vinblastine (vincaleucoblastine, VLB) and other anti-mitotic vinca alkaloid is useful in the treatment of rheumatoid arthritis and related diseases, alone or in combination with an anti-inflammatory agent.
REFERENCES:
T. Y. Shen, Drug in Experimental Clin. Res. (1977), vol. II(I), pp. 1-8. _
Abstract of 14th International Cong. Rheumatism Abst. 428 & 661, 6-26-77. _
Phelps et al., J. Exp. Med. 124 145 (1966). _
Chang et al. Arthritis & Rheumatism, vol. XI, No. 2, Part 1, Apr. 1968, pp. 145-150. _
Floresheim et al., Agents & Actions, vol. 3/1 (1973), pp. 24-27. _
Fitzgerald et al., Pharmacology, 6:265-273 (1971). _
Eli Lilly and Company
Friedman Stanley J.
Rowe James L.
Whale Arthur R.
LandOfFree
Vinblastine in rheumatoid arthritis does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Vinblastine in rheumatoid arthritis, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Vinblastine in rheumatoid arthritis will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-475256